Lan Wang has worked in the field of biochemistry since 1996. Starting as a Senior Associate Scientist at Biotransplant Inc., they then moved to Takeda Pharmaceuticals (formerly Millennium) as a Senior Research Associate in 2000. In 2002, they became a Senior Research Investigator at Praecis Pharmaceuticals, and then a Research Scientist in 2004 at Foldrx Pharmaceuticals (acquired by Pfizer). In 2007, they joined Novartis as a Scientist II Analytical Biochemistry, where they developed hydrophobic interaction chromatography, ion exchange chromatography, gel filtration, Ni-affinity and human albumin affinity purifications for protein and lipid-proteins, as well as endotoxin removal methods by applying detergents. Lan has been a Principal Scientist at Gel4Med, LLC since 2015.
Lan Wang holds a Doctor of Medicine (M.D.) from China Medical University and a Master of Science (M.Sc.) from UMass Boston, where they studied Biotechnology and Biomedical Science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices